Neuropathology for the Neuroradiologist: Rosenthal Fibers

References

1. ↵
   Cohen AR. Expanding cava septi pellucidi and cava vergae in children: report of three cases. Neurosurgery 1998;42:674–75

   PubMed
2. ↵
   Schacht J, Hawkins JE. Sketches of otohistory. Audiol Neurotol 2005;10:243–47
3. ↵
   Rosenthal W. Über eine eigenthümliche, mit Syringomyelie complicirte Geschwulst des Ruckenmarks. Beitrage zur pathologischen Anatomie und zur allgemeinen Pathologie 1898;23:111–43
4. ↵
   Zülch KJ. Tumors of neuroepithelial tissue. In: Brain tumors: their biology and pathology. 3rd ed rev. Berlin: Springer-Verlag:1986 :210–343
5. ↵
   Bielschowsky M, Unger E. Syringomyelie mit Teratom- und extramedullärer Blastombildung. Zur Kenntnis der Pathogenese der Syringomyelie. Jahrb f Psychol u Neurol 1920;25:173–218
6. ↵
   Grcevic N, Yates PO. Rosenthal fibers in tumours of the central nervous system. J Pathol Bacteriol 1957;73:467–72

   CrossRef
7. Tannenberg J. Über die Pathogenese der Syringomyelie, zugleich ein Beitrag zum Vorkommen von Capillarhämangiomen im Rückenmark. Ztschr f d ges Neurol u Psychiat 1924;92:119–74

   CrossRef
8. Landau M. Über Rückbildungsvorgänge in Gliomen. Frankf Z Pathol 1911;7:351–72
9. ↵
   Opalski A. Studien zur allgemeinen Histopathologie der Ventrikelwände. Z Neurol Psychiat 1934;150:42–74
10. ↵
    Alexander WS. Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic patient. Brain 1949;72:373–81

    FREE Full Text
11. ↵
    Seilhean D, DeGirolami U, Gray F. Basic pathology of the central nervous system. In: Gray F, DeGirolami U, Poirer J, eds. Escourolle and Poirer manual of basic neuropathology. Philadelphia: Butterworth Heinemann;2004 :1–20
12. ↵
    Fuller GN, Goodman JC. Cells of the nervous system and specialized regional organs: normal, aged, and pathological. In: Practical review of neuropathology. Philadelphia: Lippincott Williams & Wilkins;2001 :7–73
13. ↵
    Burger PC, Scheithauer BW. Tumors of neuroglia and choroid plexus epithelium. In: Atlas of tumor pathology: tumors of the central nervous system. Washington DC: Armed Forces Institute of Pathology;1994 :25–159
14. ↵
    Poirer J, Gray F, Escourolle R. Basic pathology of the central nervous system. In: Manual of basic neuropathology. Philadelphia: WB Saunders;1990 :1–16
15. ↵
    Khobayashi S, Mori H, Ikeuchi S, Takakura K. Immunohistochemical study on rosenthal fibers in gliomas using anti-GFAP and anti-ubiquitin antibodies. No Tu Shinkei 1990;42:59–64
16. ↵
    Herndon RM, Rubinstein LJ, Freeman JM. Light and electron microscopic observations on Rosenthal fibers in Alexander’s disease and in multiple sclerosis. J Neuropathol Exp Neurol 1970;29:524–51

    PubMedWeb of Science
17. ↵
    Liberski PP, Kordek R. Ultrastructural pathology of glial brain tumors revisited: a review. Ultrastruct Pathol 1997;21:1–31

    PubMed
18. ↵
    Fuller G. Time to revise the textbooks: the Rosenthal fibers of Alexander disease are associated with mutations in GFAP. Adv Anat Pathol 2001;8:357–58
19. ↵
    McLendon RE, Enterline DS, Tien RD, et al. Tumors of central neuroepithelial origin. In: Bigner DD, McLendon RE, Bruner JM, eds. Russell and Rubinstein’s pathology of tumors of the nervous system, 6th ed. London: Arnold;1998 :307–571
20. ↵
    Bonnin JM, Rubinstein LJ. Immunohistochemistry of central nervous system tumors. J Neurosurg 1984;60:1121–33

    CrossRefPubMedWeb of Science
21. ↵
    Gomes FCA, Paulin D, Moura Neto V. Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res 1999;32:619–31

    PubMedWeb of Science
22. ↵
    Rutka JT, Murakami M, Dirks PB, et al. Role of glial filaments in cells and tumors of glial origin: a review. J Neurosurg 1997;87:420–30

    PubMedWeb of Science
23. ↵
    Dahl D, Bignami A. Intermediate filaments in nervous tissue. Cell Muscle Motil 1985;6:75–96

    PubMed
24. ↵
    Tomokane N, Iwaki T, Tateishi J, et al. Rosenthal fibers share epitopes with alpha B-crystallin, glial fibrillary acidic protein, and ubiquitin, but not vimentin: immunoelectron microscopy with colloidal gold. Am J Pathol 1991;138:875–85

    PubMedWeb of Science
25. ↵
    Messing A, Goldman JE, Johnson AB, et al. Alexander disease: new insights from genetics. J Neuropathol Exp Med 2001;60:563–73
26. ↵
    Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 1985;8:203–14

    CrossRefPubMedWeb of Science
27. ↵
    Eng LF, Ghirnikar RS, Lee Y. Glial fibrillary acidic protein: GFAP-thirty-one years (1969–2000). Neurochem Res 2000;25:1439–51

    CrossRefPubMedWeb of Science
28. ↵
    Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 2004;204:428–37

    CrossRefPubMedWeb of Science
29. ↵
    Eng LF, Rubinstein LJ. Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors. J Histochem Cytochem 1978;26:513–22

    FREE Full Text
30. ↵
    Smith DA, Lantos PL. Immunocytochemistry of cerebellar astrocytomas: with a special note on Rosenthal fibers. Acta Neuropathol 1985;66:155–59

    PubMed
31. ↵
    van der Meulen JDM, Houthoff HJ, Ebels EJ. Glial fibrillary acidic protein in human gliomas. Neuropathol Appl Neurobiol 1978;4:177–90

    CrossRefPubMedWeb of Science
32. ↵
    van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 2001;22:541–52

    Abstract/FREE Full Text
33. ↵
    Hsiao VC, Tian R, Long H, et al. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. J Cell Sci 2005;118:2057–65

    Abstract/FREE Full Text
34. ↵
    Okazaki H. General methodology and pathologic cellular reactions. In: Fundamentals of neuropathology: morphologic basis of neurologic disorders. New York: Igaku-Shoin;1989 :1–26
35. ↵
    Janzer RC, Friede RL. Do Rosenthal fibers contain glial fibrillary acid protein? Acta Neuropathol (Berlin) 1981;55:75–76

    CrossRefPubMed
36. ↵
    Bettica A, Johnson AB. Ultrastructural immunogold labeling of glial filaments in osmicated and unosmicated epoxy-embedded tissue. J Histochem Cytochem 1990;38:103–09

    Abstract/FREE Full Text
37. ↵
    Goldman JE. Isolation of a major protein component of Rosenthal fibers. Am J Pathol 1988;130:569–78

    PubMedWeb of Science
38. ↵
    Li R, Messing A, Goldman JE, et al. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002;20:259–68

    CrossRefPubMedWeb of Science
39. ↵
    Murayama S, Bouldin TW, Suzuki K. Immunocytochemical and ultrastructural studies of eosinophilic granular bodies in astrocytic tumors. Acta Neuropathol 1992;83:408–14

    CrossRefPubMed
40. ↵
    Lowe J, Blanchard A, Morrell K, et al. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease, and Alzheimer’s disease, as well as Rosenthal fibers in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J Pathol 1988;155:9–15

    CrossRefPubMedWeb of Science
41. ↵
    Hagemann TL, Gaeta SA, Smith MA, et al. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum Mol Genet 2005;14:2443–58

    Abstract/FREE Full Text
42. Johnson AB. Alexander disease: a review and the gene. Int J Dev Neurosci 2002;29:391–94
43. ↵
    Messing A, Head MW, Galles K, et al. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 1998;152:391–98

    PubMedWeb of Science